If you can get 20% by paying... what, presumably <5% more for some ML tool that double-checks stuff and flags risky stuff... perhaps it's something we want to do.
If you can get 20% by paying... what, presumably <5% more for some ML tool that double-checks stuff and flags risky stuff... perhaps it's something we want to do.
It's entirely possible that we want better healthcare outcomes - all the historical trends point to that - but that we're more or less out of ideas how to get there on the cheap. This might be a new possibility.
In your model, why do we get improved, costlier insulin if the old thing was good enough? Because we actually want to pay more if it works better, and it doesn't mean we cut something else to make up for it. You just pay more in taxes in a subsidized model, or pay more at the pharmacy with private healthcare. There's a drug manufacturer profit motive in there, but it holds true in the added-cost ML scenario too.
So, to answer your question about 'why do we get improved, costlier insulin if the old thing was good enough' it is because the healthcare system will make more money on it. If they take a % then they are incentivized to use a more expensive version and they can justify it with the word 'better' even if the person is actually worse off as their financial situation deteriorates and they and their families are forced to cut quality of life everywhere else. They put their line for good enough at the point that makes the most value for them, not the point that is best for the patient.
Outcome is not one thing. The patient wants better health. The provider has an interest in profits. The government has an interest in optics…well anyone using “AI” does.